JPMorgan Chase & Co’s Direxion Daily S&P Biotech Bull 3X Shares LABU Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-4,851
| Closed | -$625K | – | 6444 |
|
2024
Q3 | $625K | Buy |
4,851
+2,735
| +129% | +$352K | ﹤0.01% | 3893 |
|
2024
Q2 | $240K | Sell |
2,116
-37,335
| -95% | -$4.24M | ﹤0.01% | 4194 |
|
2024
Q1 | $5.24M | Buy |
39,451
+11,324
| +40% | +$1.5M | ﹤0.01% | 2546 |
|
2023
Q4 | $3.43M | Buy |
28,127
+13,881
| +97% | +$1.69M | ﹤0.01% | 2803 |
|
2023
Q3 | $1.09M | Buy |
14,246
+3,944
| +38% | +$301K | ﹤0.01% | 3354 |
|
2023
Q2 | $1.22M | Buy |
10,302
+38
| +0.4% | +$4.5K | ﹤0.01% | 3307 |
|
2023
Q1 | $1.01M | Buy |
+10,264
| New | +$1.01M | ﹤0.01% | 3444 |
|
2022
Q3 | – | Sell |
-3,072
| Closed | -$414K | – | 5685 |
|
2022
Q2 | $414K | Buy |
3,072
+1,247
| +68% | +$168K | ﹤0.01% | 3979 |
|
2022
Q1 | $572K | Buy |
1,825
+1,012
| +124% | +$317K | ﹤0.01% | 3927 |
|
2021
Q4 | $586K | Buy |
813
+790
| +3,435% | +$569K | ﹤0.01% | 3970 |
|
2021
Q3 | $25K | Buy |
23
+16
| +229% | +$17.4K | ﹤0.01% | 5096 |
|
2021
Q2 | $10K | Sell |
7
-27
| -79% | -$38.6K | ﹤0.01% | 5212 |
|
2021
Q1 | $53K | Buy |
+34
| New | +$53K | ﹤0.01% | 4783 |
|